Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC-CIK vs IL-2/IFN-α in Renal Cell Carcinoma
NCT00862303Phase 2Unknown
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Mar 2009
- Primary completion
- Jun 2015
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of dendritic cell vaccine + cytokine-induced killer cells in renal cell carcinoma (RCC), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Status: unknown.
02
Drugs
dendritic cell vaccine + cytokine-induced killer cells
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00862303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862303.